RxSight, Inc., an ophthalmic medical device company, announced the pricing of its initial public offering of 7,350,000 shares of common stock at a public offering price of $16.00 per share.
PlatoAi. Web3 Reimagined. Data Intelligence Amplified.
Click here to access.